Under construction – not a live service
Sign in
Not yet taking people in EgyptNo phase

Comparing Tuberculosis Tests in People With and Without Weakened Immunity

Studies tuberculosis tests in people with normal and weakened immune systems.

Plain-language title generated from the registry record
Registry title: Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients

Key facts

Where
Sohag, EgyptSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 16 and 60 years old?

Source: NCT06709157, who can take part

Where in Egypt

  • Faculty of MedicineSohag, EgyptNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Sohag University
Trial code
NCT06709157
Record updated
29 November 2024
Original description
Tuberculosis (TB) is caused by Mycobacterium tuberculosis and is one of the top 10 causes of mortality worldwide. It is estimated that in 2017, 10 million people were infected with TB, and 1.6 million died from the disease, including 0.3 million people with human immunodeficiency virus (HIV) infection . TB remains the primary killer of HIV-positive individuals. TB incidence is falling at about 2% per year . Airborne transmission of M. tuberculosis typically causes TB infection in both immunocompetent and immunocompromised hosts and the disease is symptomatic and contagious .Read full original descriptionShow less

Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients

Tuberculosis (TB) is caused by Mycobacterium tuberculosis and is one of the top 10 causes of mortality worldwide. It is estimated that in 2017, 10 million people were infected with TB, and 1.6 million died from the disease, including 0.3 million people with human immunodeficiency virus (HIV) infection . TB remains the primary killer of HIV-positive individuals. TB incidence is falling at about 2% per year . Airborne transmission of M. tuberculosis typically causes TB infection in both immunocompetent and immunocompromised hosts and the disease is symptomatic and contagious .

Inclusion: Patients with chronic chest disease.

Exclusion: Patients with other respiratory or infectious diseases.

ClinicalTrials.gov NCT06709157